Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Functional assays for classification of BRCA2 variants of uncertain significance.
Cancer Res. 2008 May 1;68(9):3523-31. doi: 10.1158/0008-5472.CAN-07-1587.
Cancer Res. 2008.
PMID: 18451181
Free PMC article.
TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.
Sinclair CS, Adem C, Naderi A, Soderberg CL, Johnson M, Wu K, Wadum L, Couch VL, Sellers TA, Schaid D, Slezak J, Fredericksen Z, Ingle JN, Hartmann L, Jenkins RB, Couch FJ.
Sinclair CS, et al. Among authors: wadum l.
Cancer Res. 2002 Jul 1;62(13):3587-91.
Cancer Res. 2002.
PMID: 12097257
Item in Clipboard
Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Spurdle AB, Fahey P, Chen X, McGuffog L; kConFab; Easton D, Peock S, Cook M; EMBRACE; Simard J; INHERIT; Rebbeck TR; MAGIC; Antoniou AC, Chenevix-Trench G.
Spurdle AB, et al.
Breast Cancer Res Treat. 2010 Jul;122(1):281-5. doi: 10.1007/s10549-009-0601-0. Epub 2009 Nov 18.
Breast Cancer Res Treat. 2010.
PMID: 19921428
Free PMC article.
Item in Clipboard
Cite
Cite